Redefining Stem Cell Based Therapy
Our technology addresses one of the biggest challenges in regenerative medicine
Why Our Technology Stands Out
Our proprietary Suspension-Induced Stem Cell Transition (SIST) technology offers significant advantages over traditional stem cell therapy approaches.
Safety First
Our technology bypasses the need of exogenous transgenes or viral vectors, negating the risk of viral genome integration, genetic instability and tumorigenesis.
High-Yield and Scalable
Our process can be scaled to meet the demands of large-scale stem cell therapies.
Tissue Specificity
Our method generates adult stem cells (ASCs) tailored to specific tissue types, enhancing their therapeutic relevance for targeted regenerative treatments.
Transforming the Future of Regenerative Medicine
ADVANCING THE FRONTIERS OF REGENERATIVE MEDICINE BY TRANSFORMING INNOVATIVE RESEARCH INTO PRACTICAL CLINICAL APPLICATIONS
Multiple pipelines of autograft stem cell therapies in development
Our cutting-edge Suspension-Induced Stem Cell Transition (SIST) technology delivers a remarkable 100X increase in ASC yield, offering a highly scalable and safe solution for treating many diseases.
Cartilage Regeneration Therapy
Our innovative, patented method generates functional chondrocytes—specialized cartilage-producing cells—from readily accessible somatic skin cells, eliminating the need for invasive bone marrow procedures.
Wound Healing Therapy
Our scalable, patient-friendly method meets the growing need for generating human keratinocyte stem cells, which are essential for effective wound repair and skin regeneration.
We'd Love To Hear From You
Have questions about our stem cell therapies or interested in potential collaborations? We're here to help and eager to explore possibilities together.